BlackRock Japan’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$145M Buy
2,031,170
+14,487
+0.7% +$1.08M 0.48% 39
2016
Q3
$160M Buy
2,016,683
+82,963
+4% +$6.74M 0.55% 38
2016
Q2
$161M Sell
1,933,720
-77,511
-4% -$6.88M 0.58% 38
2016
Q1
$185M Sell
2,011,231
-9,990
-0.5% -$901K 0.69% 30
2015
Q4
$205M Buy
2,021,221
+5,002
+0.2% +$520K 0.76% 25
2015
Q3
$198M Buy
2,016,219
+67,598
+3% +$7.51M 0.79% 22
2015
Q2
$228M Buy
1,948,621
+31,036
+2% +$3.39M 0.88% 15
2015
Q1
$188M Sell
1,917,585
-103,130
-5% -$10.5M 0.75% 19
2014
Q4
$190M Buy
2,020,715
+140,744
+7% +$14.6M 0.73% 23
2014
Q3
$200M Buy
1,879,971
+122,662
+7% +$12M 0.86% 15
2014
Q2
$146M Sell
1,757,309
-167,766
-9% -$13.1M 0.67% 25
2014
Q1
$136M Sell
1,925,075
-79,245
-4% -$6.22M 0.61% 32
2013
Q4
$151M Buy
2,004,320
+198,055
+11% +$13.8M 0.67% 25
2013
Q3
$114M Sell
1,806,265
-176,665
-9% -$10.6M 0.54% 34
2013
Q2
$102M Buy
+1,982,930
New +$103M 0.47% 40

Other funds holding GILD

BlackRock Japan's GILD Position: Q4 2016 in Review

BlackRock Japan increased its Gilead Sciences (GILD) stake by 0.72% in Q4 2016, buying an estimated $1.08M and bringing the position to 2,031,170 shares worth $145M. The position accounts for 0.48% of the portfolio, ranked #39.

BlackRock Japan first reported a position in GILD in Q2 2013 and has held it in 15 quarters since. The position peaked at $228M in Q2 2015. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • BlackRock Japan held 2,031,170 shares of Gilead Sciences worth $145M as of Q4 2016.
  • BlackRock Japan bought 14,487 Gilead Sciences shares in Q4 2016, an estimated $1.08M.
  • Gilead Sciences made up 0.48% of BlackRock Japan's portfolio in Q4 2016, its #39 holding.
  • BlackRock Japan first reported a position in Gilead Sciences in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Japan's Gilead Sciences position peaked at $228M in Q2 2015.
  • 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.